When ADAMTS13 activity is severely reduced, these oversized vWF multimers persist in the circulation, promoting unchecked platelet adhesion and aggregation even in the absence of significant injury. Hemolytic Uremic Syndrome (HUS) HUS is typically categorized into two main etiologies, both leading to endothelial damage and subsequent schistocyte formation.
How ADAMTS13 Deficiency Drives Schistocyte Formation and HUS
This leads to the formation of widespread, platelet-rich microthrombi that shear red blood cells, causing the characteristic schistocytes and profound thrombocytopenia. This process directly generates the fragmented cells observed on the blood smear and is a hallmark of several serious disorders.
Schistocytes, fragmented red blood cells visible on a peripheral blood smear, are a critical hematologic finding that signals underlying mechanical or pathologic destruction of the erythrocyte. The two primary TMA classifications that prominently feature schistocytes are Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic Uremic Syndrome (HUS), each with distinct triggers but overlapping pathophysiology.
How ADAMTS13 Deficiency Drives Schistocytes Formation in HUS
In MAHA, the endothelial lining of small blood vessels becomes damaged or altered, creating a pathologically turbulent environment. In both scenarios, the injury to the endothelial lining of renal microvasculature creates a pro-thrombotic surface that facilitates red cell fragmentation.
More About Schistocytes cause
Looking at Schistocytes cause from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Schistocytes cause can make the topic easier to follow by connecting earlier points with a few simple takeaways.
